Skip to main content

Table 3 Immunophenotypic characterization of mesenchymal stromal cells

From: Comprehensive characterization of chorionic villi-derived mesenchymal stromal cells from human placenta

  CV-MSC (%) BM-MSC (%) UC-MSC (%) AT-MSC (%)
CD44 94.9 97.4 93.3 93.9
CD73 83.4 74.2 82.2 96.4
CD105 76.3 95.7 66.3 94.0
CD90 40.8 81.0 85.8 96.9
HLA-ABC 51.1 81.0 81.9 81.0
CD34 1.4 0.5 1.5 2.5
CD45 0.3 0.2 3.4 0.1
α-SMA 92.5 18.4 9.8 27.5
SM22α 50.5 48.4 45.7
CD49a 71.2 91.2 52.7
CD146 64.3 18.8 52.1 63.1
CD166 63.2 73.1 53.6 85.2
CD106 62.5 68.0 61.2 4.3
Stro-1 44.0 9.8 2.6 2.3
vWF 18.4 12.5 6.3 6.2
CD14 14.1 2.0 1.1 0.1
CD19 2.4 0.5 0.3
CD56 4.5 3.5 2.8 2.0
HLA-DR 0.3 0.2 0.2 0.2
CD40 2.6 2.8 1.6
CD80 0.6 0.4 0.7
CD83 2.0 3.0 2.6
CD86 0.9 0.3 0.2
CD275 1.1 0.2 0.1
CD16 5.6
CD31 0.1
CD49d 42.2
CD13 75.2
CD29 98.2
  1. Results expressed as mean percentage of marker expression. CV-MSC of passages 3–5 (n = 5), BM-MSC of passages 2–3 (n = 4), UC-MSC of passage 2 (n = 4), AT-MSC of passages 2–4 (n = 8)
  2. AT adipose tissue, BM bone marrow, CV chorionic villi, MSC mesenchymal stromal cells, UC umbilical cord